TR Biofab Valuation
| 246710 Stock | KRW 5,240 130.00 2.42% |
At this time, the company appears to be overvalued. TR Biofab owns a latest Real Value of W4869.9 per share. The recent price of the company is W5240.0. Our model measures the value of TR Biofab from analyzing the company fundamentals such as Profit Margin of (0.85) %, current valuation of 534.22 B, and Return On Equity of -36.36 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that TR Biofab's price fluctuation is very steady at this time. Calculation of the real value of TR Biofab is based on 3 months time horizon. Increasing TR Biofab's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since TR Biofab is currently traded on the exchange, buyers and sellers on that exchange determine the market value of 246710 Stock. However, TR Biofab's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5240.0 | Real 4869.9 | Hype 5370.0 | Naive 4989.93 |
The real value of 246710 Stock, also known as its intrinsic value, is the underlying worth of TR Biofab Company, which is reflected in its stock price. It is based on TR Biofab's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of TR Biofab's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of TR Biofab Co helps investors to forecast how 246710 stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of TR Biofab more accurately as focusing exclusively on TR Biofab's fundamentals will not take into account other important factors: TR Biofab Total Value Analysis
TR Biofab Co is presently forecasted to have takeover price of 534.22 B with market capitalization of 101.49 B, debt of 29.81 B, and cash on hands of 23.66 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the TR Biofab fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
534.22 B | 101.49 B | 29.81 B | 23.66 B |
TR Biofab Investor Information
About 32.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. TR Biofab had 2:1 split on the 5th of April 2022. Based on the measurements of operating efficiency obtained from TR Biofab's historical financial statements, TR Biofab Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.TR Biofab Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. TR Biofab has an asset utilization ratio of 3.93 percent. This suggests that the Company is making W0.0393 for each dollar of assets. An increasing asset utilization means that TR Biofab Co is more efficient with each dollar of assets it utilizes for everyday operations.TR Biofab Ownership Allocation
The market capitalization of TR Biofab Co is W101.49 Billion. TR Biofab shows serious amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.TR Biofab Profitability Analysis
The company reported the revenue of 3.23 B. Net Loss for the year was (11.08 B) with profit before overhead, payroll, taxes, and interest of 2.64 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates TR Biofab's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in TR Biofab and how it compares across the competition.
About TR Biofab Valuation
The stock valuation mechanism determines TR Biofab's current worth on a weekly basis. Our valuation model uses a comparative analysis of TR Biofab. We calculate exposure to TR Biofab's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of TR Biofab's related companies.TR Biofab Co., Ltd. researches and develops medical devices for transplantation and tissue regeneration in the areas of orthopedics, plastic surgery, and dentistry. The company was founded in 2013 and is based in Siheung, South Korea. TR Biofab is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct TR Biofab's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates TR Biofab's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct TR Biofab's valuation analysis, follow these 8 steps:- Gather financial information: Obtain TR Biofab's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine TR Biofab's revenue streams: Identify TR Biofab's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research TR Biofab's industry and market trends, including the size of the market, growth rate, and competition.
- Establish TR Biofab's growth potential: Evaluate TR Biofab's management, business model, and growth potential.
- Determine TR Biofab's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate TR Biofab's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for 246710 Stock analysis
When running TR Biofab's price analysis, check to measure TR Biofab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TR Biofab is operating at the current time. Most of TR Biofab's value examination focuses on studying past and present price action to predict the probability of TR Biofab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TR Biofab's price. Additionally, you may evaluate how the addition of TR Biofab to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |